| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jun 04, 2025 | Jun 07, 2025 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $36.96 | $100,716 | -1.11% |
| May 07, 2025 | May 10, 2025 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $35.75 | $97,419 | -1.10% |
| Apr 02, 2025 | Apr 05, 2025 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $36.22 | $139,801 | -1.54% |
| Mar 05, 2025 | Mar 08, 2025 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $30.48 | $48,463 | -0.63% |
| Feb 05, 2025 | Feb 08, 2025 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $40.69 | $143,229 | -1.37% |
| Jan 02, 2025 | Jan 04, 2025 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $46.94 | $191,740 | -1.57% |
| Dec 11, 2024 | Dec 14, 2024 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $48.76 | $221,363 | -1.73% |
| Dec 04, 2024 | Dec 07, 2024 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $46.07 | $307,057 | -2.49% |
| Nov 06, 2024 | Nov 09, 2024 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $59.12 | $394,041 | -2.43% |
| Oct 02, 2024 | Oct 05, 2024 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $56.26 | $374,954 | -2.37% |
| Sep 04, 2024 | Sep 07, 2024 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $47.56 | $316,969 | -2.32% |
| Aug 07, 2024 | Aug 10, 2024 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $40.67 | $298,336 | -2.49% |
| Jul 03, 2024 | Jul 06, 2024 | Dambkowski Carl Chief Medical Officer | Sell | Apogee Therapeutics, Inc. | APGE | $37.6 | $225,418 | -1.99% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.